UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

The Impact of Longitudinal Data‐Completeness of Electronic Health Record Data on the Prediction Performance of Clinical Risk Scores

Clinical pharmacology and therapeutics, 2023-06, Vol.113 (6), p.1359-1367

2023

Link zum Volltext

Verfügbarkeit prüfen

A systematic approach towards missing lab data in electronic health records: A case study in non-small cell lung cancer and multiple myeloma

CPT: pharmacometrics and systems pharmacology, 2023-09, Vol.12 (9), p.1201-1212

2023

Link zum Volltext

Verfügbarkeit prüfen

Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study

Scientific reports, 2017-06, Vol.7 (1), p.2911-11, Article 2911

2017

Link zum Volltext

Verfügbarkeit prüfen

Artificial Intelligence for Prognostic Scores in Oncology: a Benchmarking Study

Frontiers in artificial intelligence, 2021-04, Vol.4, p.625573-625573

2021

Link zum Volltext

Verfügbarkeit prüfen

Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States

Cancers, 2020-09, Vol.12 (9), p.2419

2020

Link zum Volltext

Verfügbarkeit prüfen

Changes in population‐level survival for advanced solid malignancies with new treatment options in the second decade of the 21st century

Cancer, 2019-08, Vol.125 (15), p.2656-2665

2019

Link zum Volltext

Verfügbarkeit prüfen

The FAIRification of research in real‐world evidence: A practical introduction to reproducible analytic workflows using Git and R

Pharmacoepidemiology and drug safety, 2024-01, Vol.33 (1), p.e5740-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparison of response from RECIST1.1 and abstraction in real-world patients with lung cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21194-e21194

2023

Link zum Volltext

Verfügbarkeit prüfen

Beta blockers and cancer prognosis – the role of immortal time bias: A systematic review and meta-analysis

Cancer treatment reviews, 2016-06, Vol.47, p.1-11

2016

Link zum Volltext

Verfügbarkeit prüfen

The Association of Potentially Inappropriate Medication at Older Age With Cardiovascular Events and Overall Mortality: A Systematic Review and Meta-Analysis of Cohort Studies

Journal of the American Medical Directors Association, 2017-03, Vol.18 (3), p.211-220

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term heart-specific mortality among 347 476 breast cancer patients treated with radiotherapy or chemotherapy: a registry-based cohort study

European heart journal, 2018-11, Vol.39 (43), p.3896-3903

2018

Link zum Volltext

Verfügbarkeit prüfen

Epidemiologische Forschung mit Krebsregisterdaten

Onkologie (Heidelberg, Germany), 2017-04, Vol.23 (4), p.272-279

2017

Link zum Volltext

Verfügbarkeit prüfen

Updated Population Based Survival Analysis in Patients with Chronic Myeloid Leukemia: Increased Survival but Continued Disparities for Older Patients

Blood, 2017-12, Vol.130, p.2192-2192

2017

Link zum Volltext

Verfügbarkeit prüfen

Population Level Survival for Patients with Multiple Myeloma By Insurance Type and Early Indications of Changes with Adoption of the Medicaid Expansion of the Affordable Care Act

Blood, 2017-12, Vol.130, p.3438-3438

2017

Link zum Volltext

Verfügbarkeit prüfen

Tumor mutational burden as a predictive biomarker for immune checkpoint inhibitor versus taxane chemotherapy benefit in metastatic castration-resistant prostate cancer: A real-world biomarker study

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.162-162

2022

Link zum Volltext

Verfügbarkeit prüfen

Pre‐ and post‐diagnostic beta‐blocker use and prognosis after colorectal cancer: Results from a population‐based study

International journal of cancer, 2017-07, Vol.141 (1), p.62-71

2017

Link zum Volltext

Verfügbarkeit prüfen

Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century

International journal of cancer, 2018-07, Vol.143 (2), p.324-332

2018

Link zum Volltext

Verfügbarkeit prüfen

Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century

Haematologica (Roma), 2017-06, Vol.102 (6), p.e229-e232

2017

Link zum Volltext

Verfügbarkeit prüfen

A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype

Journal of the American Academy of Dermatology, 2019-04, Vol.80 (4), p.938-946

2019

Link zum Volltext

Verfügbarkeit prüfen

Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis

European journal of epidemiology, 2017-11, Vol.32 (11), p.1019-1031

2017

Link zum Volltext

Verfügbarkeit prüfen

Predicting medication-associated altered mental status in hospitalized patients: Development and validation of a risk model

American journal of health-system pharmacy, 2019-06, Vol.76 (13), p.953-963

2019

Link zum Volltext

Verfügbarkeit prüfen

Survival of Patients with Rare Plasma Cell or Lymphoplasmacytoid Malignancies in Germany and the United States in the Early 21st Century

Blood, 2016-12, Vol.128 (22), p.4767-4767

2016

Link zum Volltext

Verfügbarkeit prüfen

Population Level Survival for Patients with Rare Hematologic Malignancies in the United States in the Early 21st Century

Blood, 2016-12, Vol.128 (22), p.2416-2416

2016

Link zum Volltext

Verfügbarkeit prüfen

Comment on: 'β Blocker use and mortality in cancer patients: systematic review and meta-analysis of observational studies' (Zhong et al., 2015; published Epub ahead of print 3 September 2015)

European journal of cancer prevention, 2018-01, Vol.27 (1), p.103

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel

Multiple sclerosis and related disorders, 2022-12, Vol.68, p.104153-104153, Article 104153

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(33)

Sprache

Englisch
(31)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(4)
Clinical Epidemiology
(2)
Haematologica
(2)
International Journal Of Cancer
(2)
Journal Of Clinical Oncology
(2)
American Journal Of Health-System Pharmacy
(1)
Cancer
(1)
Cancer Research
(1)
Cancer Treatment Reviews
(1)
Cancers
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Impact of Longitudinal Data‐Completeness of Electronic Health Record Data on the Prediction Performance of Clinical Risk Scores

A systematic approach towards missing lab data in electronic health records: A case study in non-small cell lung cancer and multiple myeloma

Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study

Artificial Intelligence for Prognostic Scores in Oncology: a Benchmarking Study

Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States

Changes in population‐level survival for advanced solid malignancies with new treatment options in the second decade of the 21st century

The FAIRification of research in real‐world evidence: A practical introduction to reproducible analytic workflows using Git and R

Comparison of response from RECIST1.1 and abstraction in real-world patients with lung cancer

Beta blockers and cancer prognosis – the role of immortal time bias: A systematic review and meta-analysis

The Association of Potentially Inappropriate Medication at Older Age With Cardiovascular Events and Overall Mortality: A Systematic Review and Meta-Analysis of Cohort Studies

Long-term heart-specific mortality among 347 476 breast cancer patients treated with radiotherapy or chemotherapy: a registry-based cohort study

Epidemiologische Forschung mit Krebsregisterdaten

Updated Population Based Survival Analysis in Patients with Chronic Myeloid Leukemia: Increased Survival but Continued Disparities for Older Patients

Population Level Survival for Patients with Multiple Myeloma By Insurance Type and Early Indications of Changes with Adoption of the Medicaid Expansion of the Affordable Care Act

Tumor mutational burden as a predictive biomarker for immune checkpoint inhibitor versus taxane chemotherapy benefit in metastatic castration-resistant prostate cancer: A real-world biomarker study

Pre‐ and post‐diagnostic beta‐blocker use and prognosis after colorectal cancer: Results from a population‐based study

Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century

Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century

A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype

Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis

Predicting medication-associated altered mental status in hospitalized patients: Development and validation of a risk model

Survival of Patients with Rare Plasma Cell or Lymphoplasmacytoid Malignancies in Germany and the United States in the Early 21st Century

Population Level Survival for Patients with Rare Hematologic Malignancies in the United States in the Early 21st Century

Comment on: 'β Blocker use and mortality in cancer patients: systematic review and meta-analysis of observational studies' (Zhong et al., 2015; published Epub ahead of print 3 September 2015)

Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel

Suchergebnisse filtern